Genes and proteins, and their uses
OwnerJonathan Douglas Lane, Martin John Glenton Hughes +1inventors
InventorsJonathan Douglas Lane, Martin John Glenton Hughes, Joseph David Santangelo
Life of this patent
Estimating the term…
Abstract
A series of genes from Neisseria meningitidis are shown to encode products which are targets for immunisation. The identification of these genes therefore allows vaccines to be produced and other therapeutic products.
Claims16
A peptide encoded by a gene including any of the nucleotide sequences identified herein as SEQ ID NOS. 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31 and 33, of N. meningitidis, or a homologue thereof in a Gram-negative bacterium, or a functional fragment thereof, for therapeutic or diagnostic use.
A peptide according to any preceding claim, wherein the homologue has at least 90% sequence similarity or identity at the peptide or nucleotide level.
A polynucleotide encoding a peptide according to any preceding claim, for therapeutic or diagnostic use.
Dependencies are inferred from the claim text.